4.7 Article

7,8-Dichloro-1-oxo-β-carbolines as a Versatile Scaffold for the Development of Potent and Selective Kinase Inhibitors with Unusual Binding Modes

期刊

JOURNAL OF MEDICINAL CHEMISTRY
卷 55, 期 1, 页码 403-413

出版社

AMER CHEMICAL SOC
DOI: 10.1021/jm201286z

关键词

-

资金

  1. Structural Genomics Consortium [1097737]
  2. Canadian Institutes for Health Research
  3. Canadian Foundation for Innovation
  4. Genome Canada through the Ontario Genomics Institute
  5. GlaxoSmithKline
  6. Karolinska Institutet
  7. Knut and Alice Wallenberg Foundation
  8. Ontario Innovation Trust
  9. Ontario Ministry for Research and Innovation
  10. Merck Co., Inc.
  11. Novartis Research Foundation
  12. Swedish Agency for Innovation Systems
  13. Swedish Foundation for Strategic Research
  14. Wellcome Trust

向作者/读者索取更多资源

Development of both potent and selective kinase inhibitors is a challenging task in modern drug discovery. The innate promiscuity of kinase inhibitors largely results from ATP-mimetic binding to the kinase hinge region. We present a novel class of substituted 7,8-dichloro-1-oxo-beta-carbolines based on the distinct structural features of the alkaloid bauerine C whose kinase inhibitory activity does not rely on canonical ATP-mimetic hinge interactions. Intriguingly, cocrystal structures revealed an unexpected inverted binding mode and the presence of halogen bonds with kinase backbone residues. The compounds exhibit excellent selectivity over a comprehensive panel of human protein kinases while inhibiting selected kinases such as the oncogenic PIM1 at low nanomolar concentrations. Together, our biochemical and structural data suggest that this scaffold may serve as a valuable template for the design and development of specific inhibitors of various kinases including the PIM family of kinases, CLKs, DAPK3 (ZIPK), BMP2K (BIKE), and others.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据